PharmaCongress - The Leading Forum on Pharmaceutical, Biotechnology and Genomics Regulation and Compliance

Overview | Agenda/Faculty Materials | Continuing Education | Promotional Opportunities
Order CDs | Contact Us | Past Conferences | Privacy Policy | Administration | Home


Preconference
Precon - Day One
Precon - Day Two



Conference
Day One
Day Two
Day Three

 

Agenda: Day 3
Wednesday, November 17, 2004



8:00 a.m.

Welcome and Introduction to Day 3

Brenton L. Saunders, JD, MBA
Senior Vice President
Global Compliance and Business Practices
Schering-Plough Corporation
Past President, Health Care Compliance Association
Founder, International Association of Privacy Professionals
Kenilworth, NJ
(Conference Co chair)

8:05 a.m.

Update on FTC Regulation of Pharmaceutical Enterprises

Mozelle W. Thompson, Esq.
Former Commissioner, Federal Trade Commission
Washington, DC

8:30 a.m.

Prosecuting Violations in the Pharmaceutical Industry

Susan Winkler, Esq.
Assistant United States Attorney
Deputy Health Care Fraud Chief
United States Attorney's Office for the District of Massachusetts
Boston, MA

9:00 a.m.

Enforcment Trends In Pharmaceutical Cases

Gene Thirolf, Esq.
Director Office of Consumer Litigation Civil Division
United States Department of Justice
Washington, DC

9:30 a.m.

Building Trust: A Revolution in Compliance

Anthony Farino
Partner, Pharmaceutical Advisory Services Group
PricewaterhouseCoopers LLP
Chicago, IL

10:00 a.m.

An Insider's View of the Post-Election Political Landscape: Implications for Pharmaceutical Enterprises

John Ford
Minority/Democratic Staff, Energy and Commerce Committee
United States House of Representatives
Washington, DC

Robert Lively
Staff Vice President, Federal Government Affairs
Schering-Plough Corporation
Washington, DC
Presentation Material (Acrobat)
Presentation Material (Powerpoint)

Dean A. Rosen
Staff of Subcommittee on Public Health
Office of Senate Majority Leader William H. Frist, MD
United States Senate
Washington, DC

Sally Walsh
Vice President
Federal Government Relations
GlaxoSmithKline
Washington, DC

John K. Iglehart
Founding Editor, Health Affairs
National Correspondent, New England Journal of Medicine
Washington, DC
(Moderator)

10:45 a.m.

Transition Break

11:00 a.m.

Rating Compliance and Corporate Responsibility in Pharmaceutical Enterprises

Andrea M. Esposito
Managing Director
Standard & Poor's Governance Services
New York, NY
Presentation Material (Acrobat)
Presentation Material (Powerpoint)

11:30 a.m.

Qui Tam Update Panel

Thomas M. Greene, Esq.
Greene and Hoffman
Boston, MA
Presentation Material (Acrobat)
Presentation Material (Powerpoint)

Erika Kelton
Partner, Phillips & Cohen LLC
Washington, DC

Mark Allen Kleiman, Esq.
Lawyer, Law Offices of Mark Allen Kleiman
Los Angeles, CA

Robert G. Homchick, Esq.
Partner and Chair, Health Law Group
Davis Wright Tremaine
Seattle, WA
(Moderator)

12:30 p.m.

Adjournment


Overview | Agenda/Faculty Materials | Continuing Education | Promotional Opportunities
Order CDs | Contact Us | Past Conferences | Privacy Policy | Administration | Home

All material on this website is protected by copyright.
Copyright @ 2004 by Health Care Conference Administrators, LLC.
All rights reserved.

Contact Webmaster